|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 113.75 INR | -1.98% |
|
-9.00% | +58.23% |
| May. 21 | Dubai Investments says Globalpharma signs 7 strategic MoUs | RE |
| May. 20 | ZIM Laboratories Limited, Q4 2026 Earnings Call, May 20, 2026 |
| Market Cap | 6.09B 63.81M 55.82M 51.48M 47.63M 90.41M 91.92M 617M 242M 2.99B 240M 234M 10.36B | P/E 2025 |
32.1x | P/E 2026 | 50.3x |
|---|---|---|---|---|---|
| Enterprise Value | 6.95B 72.86M 63.73M 58.77M 54.38M 103M 105M 704M 276M 3.42B 274M 268M 11.83B | EV / Sales 2025 |
1.34x | EV / Sales 2026 | 1.09x |
| Free-Float |
28.65% | Yield 2025 * |
-
| Yield 2026 | - |
Last Transcript: ZIM Laboratories Limited
| 1 day | -1.98% | ||
| 1 week | -9.00% | ||
| Current month | -8.49% | ||
| 1 month | +9.96% | ||
| 3 months | +59.54% | ||
| 6 months | +68.27% | ||
| Current year | +58.23% |
| 1 week | 113.75 | 123.15 | |
| 1 month | 107 | 133.95 | |
| Current year | 59.72 | 133.95 | |
| 1 year | 59.72 | 133.95 | |
| 3 years | 59.72 | 151.75 | |
| 5 years | 36.37 | 151.75 | |
| 10 years | 14 | 151.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CEO | Chief Executive Officer | - | 2001-12-31 |
| Director of Finance/CFO | - | 2019-03-31 | |
| Director of Finance/CFO | - | 1990-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Anwar Siraj Daud
CHM | Chairman | - | 1989-12-31 |
| Director/Board Member | - | 1990-12-31 | |
Prakash Sapkal
BRD | Director/Board Member | - | 2012-12-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.98% | -9.00% | -0.39% | +7.51% | 64.9M | ||
| +2.67% | +3.88% | +15.92% | +87.19% | 47.31B | ||
| -0.81% | +3.80% | +67.17% | +112.23% | 36.04B | ||
| +0.66% | -1.06% | -3.16% | +41.21% | 12.08B | ||
| +0.96% | +4.49% | +17.88% | +99.06% | 11.96B | ||
| +0.38% | +1.95% | +34.36% | +123.93% | 9.05B | ||
| -0.08% | -0.91% | +17.07% | +43.71% | 6.92B | ||
| -1.61% | +3.42% | +58.05% | -3.09% | 7.19B | ||
| +1.96% | +4.87% | +23.86% | +228.94% | 6.55B | ||
| -2.19% | +2.95% | -21.76% | +7.68% | 5.9B | ||
| Average | +0.02% | -0.29% | +20.90% | +74.84% | 14.31B | |
| Weighted average by Cap. | +0.76% | +1.66% | +29.53% | +89.47% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.79B 39.72M 34.75M 32.04M 29.65M 56.27M 57.21M 384M 150M 1.86B 149M 146M 6.45B | 3.74B 39.22M 34.31M 31.64M 29.28M 55.57M 56.5M 379M 149M 1.84B 147M 144M 6.37B |
| Net income | 122M 1.27M 1.11M 1.03M 951K 1.81M 1.84M 12.31M 4.83M 59.74M 4.78M 4.68M 207M | 58.38M 612K 535K 493K 457K 867K 881K 5.91M 2.32M 28.67M 2.3M 2.25M 99.31M |
| Net Debt | 1.16B 12.13M 10.61M 9.78M 9.05M 17.18M 17.47M 117M 45.93M 568M 45.53M 44.54M 1.97B | 863M 9.04M 7.91M 7.29M 6.75M 12.81M 13.02M 87.35M 34.24M 424M 33.94M 33.21M 1.47B |
Employees
632
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | ₹113.75 | -1.98% | 987 |
| 26-07-08 | ₹116.05 | -1.78% | 1,878 |
| 26-07-07 | ₹118.15 | -1.99% | 857 |
| 26-07-06 | ₹120.55 | -1.99% | 732 |
| 26-07-03 | ₹123.00 | -0.08% | 2,591 |
- Stock Market
- Stocks
- ZIMLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















